definiens: means the gross amount invoiced on sales of Licen sed Product in the Territory by Poseida, its Affiliates and Sublicensees to any Thi rd Party, less the following deductions calculated in accordance with GAAP and standard internal policies and procedures and accounting standards consistent ly applied throughout the pharmaceutical industry, to the extent specifically and solely allocated to suc h Licensed Product and actually taken, paid, accrued, allowed, included or allocated, based on good faith estimat es, in the gross sales price with respect to such sales ( and c onsistently applied as set forth below ): [ … * * * … ] All aforementioned deductions shall only be allowab le to the extent they are commercially reasonable a nd shall be determined, on a country - by - country basis, as incurred in the ordinary course of business in type and amount consistent with the Party ’s, the Affilia te ’s, or Third Party Sublicensee ’s ( as the case may be ) business practices consistently applied across its product lines and accounting standards and * * * Certain Confidential Information Omitted 7 CONFIDENTIAL - [COMPANY] Biotech Inc. & Poseida Therapeutics Inc. Li cense Agreement – August 3, 2015 verifiable based on Poseida ’s sales reporting syste m. All such discounts, allowances, credits, rebates, and other deductions shall be fairly and equitably allo cated to Licensed Product and other products of the Party and its Affiliates and Sublicensees such that Licen sed Product does not bear a disproportionate portio n of such deductions